Clin Epidemiol (2019) 11:56391
Patients should not discontinue prescribed lipid-lowering medications without consulting their GP or specialist, even if weight loss occurs during Saxenda treatment
This could lead to pulmonary aspiration, respiratory infections, and other life-threatening complications
Similar content being viewed by others Background Pulmonary fibrosis is a progressive, often lethal disease characterized by limited therapeutic options and eventually irreversible lung tissue damage
Patients should report immediately if they experience any decrease in the amount of exercise that they can normally tolerate, shortness of breath, chest or heart pain, fainting or swelling in the lower legs
The $50 copay does not count toward your Part D out-of-pocket maximum (set at $2,100 in 2026 and $2,400 in 2027)